You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company and its collaborators previously published a study linking saliva concentrations of multiple microRNAs with concussion duration and symptoms in children.
In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.
Three research teams profiled proteomic, genomic, and other features in lung adenocarcinomas in Asia and other parts of the world, including cases in never-smokers.
In PNAS this week: effect of premature termination codons in the DMD gene, knock-down of DUX4 in facioscapulohumeral muscular dystrophy, and more.
In Nucleic Acids Research this week: tool to track co-expression networks, tool to prioritize variants in rare diseases, and more.
A Broad Institute-led team found that differences by ancestry could affect not only how cancer develops but also treatment approaches.
In Science this week: a microRNA regulates extracellular vesicle secretion from prostate cancer cells, and more.
In PLOS this week: host immune response to Candida infection, microbial communities of drinking water, and more.
The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort.
A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions.
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
Wired reports that Oxitec has now developed a genetically modified fall armyworm.
A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.
In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.